Article
Multiple epitopes of hepatitis B virus surface antigen targeted by human plasma-derived immunoglobulins coincide with clinically observed escape mutations.
Journal of medical virology - 1 Feb 2022
Tarafdar Sreya, Virata Maria Luisa, Yan Hailing, Zhong Lilin, Deng Lu, Xu Yanqun, He Yong, Struble Evi, Zhang Pei
Abstract excerpt
Hepatitis B immune globulin (HBIG) is a human plasma-derived immunoglobulin G concentrate that contains a high titer of neutralizing antibodies (anti-HBs) to the hepatitis B virus (HBV) surface antigen (HBsAg). HBIG is known to be highly effective in treating HBV infections, however, a more systematic characterization of the antibody binding sites on HBsAg and their correlation with emerging "escape" mutations in...
Topics
- Epitopes
- Hepatitis B
- Hepatitis B Antibodies
- Hepatitis B Surface Antigens
- Hepatitis B virus
- Humans
- Immunoglobulins
- Mutation
- Peptide Library
